LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Investments RAPT Therapeutics has attracted investments from reputable firms like TimesSquare Capital Management LLC and SG Americas Securities, indicating a potential interest in their innovative therapies and growth prospects.

Strategic Leadership Hires The recent appointments of key executives like Nipun Davar as Senior Vice President of Technical Operations and Michael Listgarten as General Counsel suggest a focus on strengthening RAPT's leadership team, potentially signaling new strategic initiatives or developments.

Targeted R&D in Oncology RAPT Therapeutics' focus on developing FLX475 for 'charged' tumors, where immune suppression is linked to T reg cells, presents a unique selling point for targeting specific cancer types, potentially opening avenues for collaborations or partnerships in the oncology space.

Market Expansion Opportunities With a revenue range of $10M - 50M and presence in the biotechnology research sector, RAPT Therapeutics could explore market expansion opportunities by leveraging their innovative small molecule therapies to address unmet needs in inflammatory diseases and oncology, potentially attracting new partners or investors.

Tech-Driven Approach Utilizing technologies like Google Analytics, Akamai, and MySQL, RAPT Therapeutics showcases a tech-savvy approach in their operations, indicating a readiness to adopt cutting-edge tools and potentially appealing to tech-focused partners or collaborators.

RAPT Therapeutics Tech Stack

RAPT Therapeutics uses 8 technology products and services including Google Analytics, Akamai, MySQL, and more. Explore RAPT Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Akamai
    Content Delivery Network
  • MySQL
    Database
  • Microsoft Access
    Database Management Software
  • web-vitals
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Adobe Creative Suite
    Visualisation Software
  • Streamlit
    Web Frameworks

Media & News

RAPT Therapeutics's Email Address Formats

RAPT Therapeutics uses at least 1 format(s):
RAPT Therapeutics Email FormatsExamplePercentage
FLast@rapt.comJDoe@rapt.com
42%
First.Last@rapt.comJohn.Doe@rapt.com
14%
First@rapt.comJohn@rapt.com
2%
FLast@rapt.comJDoe@rapt.com
42%

Frequently Asked Questions

Where is RAPT Therapeutics's headquarters located?

Minus sign iconPlus sign icon
RAPT Therapeutics's main headquarters is located at 561 Eccles Avenue South San Francisco, California 94080 US. The company has employees across 6 continents, including North AmericaEuropeAfrica.

What is RAPT Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact RAPT Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is RAPT Therapeutics's stock symbol?

Minus sign iconPlus sign icon
RAPT Therapeutics is a publicly traded company; the company's stock symbol is RAPT.

What is RAPT Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
RAPT Therapeutics's official website is rapt.com and has social profiles on LinkedIn.

How much revenue does RAPT Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, RAPT Therapeutics's annual revenue reached $15M.

What is RAPT Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
RAPT Therapeutics's SIC code is 3599 - Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does RAPT Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, RAPT Therapeutics has approximately 157 employees across 6 continents, including North AmericaEuropeAfrica. Key team members include Chief Scientific Officer: D. G. B.Chief Medical Officer: W. H.Chief Financial Officer: R. Y.. Explore RAPT Therapeutics's employee directory with LeadIQ.

What industry does RAPT Therapeutics belong to?

Minus sign iconPlus sign icon
RAPT Therapeutics operates in the Biotechnology Research industry.

What technology does RAPT Therapeutics use?

Minus sign iconPlus sign icon
RAPT Therapeutics's tech stack includes Google AnalyticsAkamaiMySQLMicrosoft Accessweb-vitalsYoast SEOAdobe Creative SuiteStreamlit.

What is RAPT Therapeutics's email format?

Minus sign iconPlus sign icon
RAPT Therapeutics's email format typically follows the pattern of . Find more RAPT Therapeutics email formats with LeadIQ.

How much funding has RAPT Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, RAPT Therapeutics has raised $71M in funding. The last funding round occurred on Nov 17, 2022 for $71M.

When was RAPT Therapeutics founded?

Minus sign iconPlus sign icon
RAPT Therapeutics was founded in 2015.
RAPT Therapeutics

RAPT Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

RAPT Therapeutics is a clinical stage immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, RPT193 and FLX475, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The company is also pursuing a range of targets that are in the discovery stage of development.

Section iconCompany Overview

Headquarters
561 Eccles Avenue South San Francisco, California 94080 US
Phone number
Website
rapt.com
SIC Code
3599 - Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified
Stock Symbol
RAPT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $71M

    RAPT Therapeutics has raised a total of $71M of funding over 8 rounds. Their latest funding round was raised on Nov 17, 2022 in the amount of $71M.

  • $10M$50M

    RAPT Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $71M

    RAPT Therapeutics has raised a total of $71M of funding over 8 rounds. Their latest funding round was raised on Nov 17, 2022 in the amount of $71M.

  • $10M$50M

    RAPT Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.